Chiauranib

Chiauranib · Chipscreen Biosciences, Ltd.

Drug timelines are a Plus or Pro feature.

13 regulatory and trial events tracked for Chiauranib, covering 2016-06-17 to 2026-03-18. Get the full timeline:

Most recent: Clinical Trial Update: Chiauranib in Patients With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma [Phase 2]